United Therapeutics CorporationUTHRNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank29
3Y CAGR-14.8%
5Y CAGR+22.1%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-14.8%/yr
Annual compound
5Y CAGR
+22.1%/yr
Recent deceleration
Percentile
P29
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 8.98% |
| 2024 | 24.04% |
| 2023 | 15.67% |
| 2022 | 14.50% |
| 2021 | 13.66% |
| 2020 | 3.31% |
| 2019 | -6.85% |
| 2018 | -11.76% |
| 2017 | 6.13% |
| 2016 | 9.26% |